Japan considers new rules for clinical trials

08/7/2013 | PharmaLive.com

Japan's Health, Labor and Welfare Ministry is considering rules to penalize companies that fail to preserve and submit clinical trial data to the government. Possible penalties include fines, revocation of drug approvals and suspension of clinical trials.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR